Abstract
Hookworm infection remains a significant public health concern, particularly in low- and middle-income countries, where mass drug administration has not stopped reinfection. Developing a vaccine is crucial to complement current control measures, which necessitates a thorough understanding of host immune responses. By leveraging controlled human infection models and high-dimensional immunophenotyping, here we investigated the immune remodeling following infection with 50 Necator americanus L3 hookworm larvae in four naïve volunteers over two years of follow-up and compared the profiles with naturally infected populations in endemic areas. Increased plasmacytoid dendritic cell frequency and diminished responsiveness to Toll-like receptor 7/8 ligand were observed in both controlled and natural infection settings. Despite the increased CD45RA+ regulatory T cell (Tregs) frequencies in both settings, markers of Tregs function, including inducible T-cell costimulatory (ICOS), tumor necrosis factor receptor 2 (TNFR2), and latency-associated peptide (LAP), as well as in vitro Tregs suppressive capacity were higher in natural infections. Taken together, this study provides unique insights into the immunological trajectories following a first-in-life hookworm infection compared to natural infections.
Subject terms: Infection, Experimental models of disease, Parasitic infection, Systems analysis
Hookworm infection remains a threat to public health where economic factors restrict treatment and lack of effective vaccination have limited successful therapeutic control which results in reinfection in endemic areas. Here the authors use a controlled human hookworm infection model and use high dimensional single cell profiling to show that plasmacytoid dendritic cells and regulatory T cells profiles that resemble those seen during natural infections in endemic areas.
Introduction
Human hookworm infection continues to cause significant health and economic burdens in low- and middle-income countries1. To reduce the morbidity caused by hookworm infection, mass drug administration (MDA) with albendazole or mebendazole has been implemented2. However, MDA does not provide the necessary protection against reinfection to break the transmission cycle. Furthermore, concerns about treatment failure with mebendazole and the possible emergence of drug resistance have been raised3, highlighting the need for a vaccine.
The rational design of vaccines requires a thorough understanding of the immune response of the host. Controlled human infection models serve as unique and promising means to study the host’s immune response, owing to the known time of infection and inoculum dose, which are difficult to determine in naturally occurring infections in endemic areas. The combination of controlled human infection models with high-dimensional immunophenotyping has revealed new insights into host-pathogen interactions, such as in malaria4,5. Although controlled human hookworm infection (CHHI) studies have involved more than 200 participants in total6, a high-dimensional analysis of the immune response to hookworm has not been performed.
In CHHI studies conducted to date, eosinophilia, the production of total and hookworm-specific immunoglobulin (Ig) E and IgG, as well as cytokine production by immune cells in culture supernatants have been reported, indicating the activation of CD4+T cells and mixed T helper 1 (TH1) or 2 (TH2) cytokine responses7,8. Here, we performed a high-dimensional mapping of cellular immunological responses in CHHI study participants who were experimentally infected with one dose of 50 Necator americanus L3 larvae and followed for two years9. Changes in the profile of peripheral blood mononuclear cells (PBMC) and intracellular cytokine production were analyzed. In addition, we examined the immune profiles of hookworm-infected Indonesians living in Flores, to see if our findings in controlled infection can be generalized to naturally occurring infections in an endemic setting.
Our study showed that controlled hookworm infection with a single dose of larvae caused numerous changes in the circulating immune cells, such as plasmacytoid dendric cells and regulatory T cells (Tregs), that showed linked trajectories and mimicked, to some degree, what is seen in naturally occurring infections. However, clear differences were also seen, which could be explained by the repeated exposure to hookworms and coinfections that might exert extra modulatory effects on the immune system.
Results
Patent infection in all participants after controlled hookworm infection
To investigate immunological changes after primary hookworm infection, four healthy hookworm-naïve volunteers were enrolled in the Controlled Human Hookworm Infection in Leiden (CHHIL) study. As previously reported9, the CHHIL study participants were infected with one dose of 50 infectious N. americanus L3 larvae and followed for two years. Peripheral blood mononuclear cells (PBMC) were isolated at seven time points (Fig. 1A). All four volunteers started excreting eggs between 8 and 10 weeks post-infection (WPI) as measured by the Kato-Katz technique (Fig. 1B). Eosinophil counts increased significantly starting at 3 WPI (P = 0.042, compared to baseline), peaked at 6 WPI (range, 2.02 × 109 – 6.96 × 109 eosinophils/L, P = 0.0001), and subsequently decreased from 12 WPI but remained significantly elevated for two years (Fig. 1C, P < 0.018)9. Adverse events were generally mild, with skin itching and rash at the site of larvae inoculation occurring shortly after the infection, and abdominal adverse events (flatulence, nausea, and abdominal cramping) were reported between 3 and 9 WPI9. These results indicate that the controlled hookworm infection resulted in a patent and tolerable infection in all participants during the two-year study period.
Hookworm infection-driven changes in immunological profiles
To characterize changes in immune cell composition after primary hookworm infection, PBMC from CHHIL participants were analyzed using mass cytometry with a 37-marker antibody panel (Table S1). Using FlowSOM clustering on the acquired cells, we obtained 45 immune cell clusters from a total of 7.8 million immune cells. The FlowSOM clusters were classified into eight immune cell lineages based on marker expression: conventional CD4+ and CD8+ αβ T cells, unconventional αβ T cells, γδ T cells, natural killer and innate lymphoid cells (NK/ILC), B cells, myeloid cells, as well as basophils (Fig. 2A, Table S2); two clusters (clusters 25 and 41) were excluded from further analysis due to lack of signal for any lineage markers. Altogether, there were few significant changes in the frequency of cells at the lineage level (Fig. S1, Supplementary Data 1). However, when analyzed on cluster level, principal component analysis (PCA) revealed highly significant segregation of the immune profiles before and after hookworm infection (Fig. 2B, PERMANOVA P < 0.001). This segregation was largely driven by increased frequencies of plasmacytoid dendritic cells (pDC, cluster 43), CD45RA+Foxp3+CD4+T cells (resting Tregs, cluster 7), and basophils (cluster 35) as well as decreased frequencies of memory CD4+T cells (clusters 4, 9, and 19) after infection (Fig. 2C). Differential abundance analysis of the cell clusters revealed that changes in FlowSOM cluster frequencies can be found as early as 4 WPI and persist up to 104 WPI (Fig. S2, Supplementary Data 2). These findings show that primary hookworm infection caused changes, starting early after infection, in the frequencies of immune cell clusters driven, among others, by the enrichment of CD45RA+ resting Tregs, pDC, and basophils.
Long-term expansion of pDC and basophils following hookworm infection
Among CHHIL participants, we found that pDC frequencies (cluster 43) increased significantly from 4 WPI, and remained elevated relative to baseline until year 2 (Fig. 2D), while basophil frequencies (cluster 35) increased from 4 WPI to 28 WPI and then normalized (Fig. 2E). We then asked to what extent changes in pDC and basophil frequencies after primary hookworm infection lasting two years, mirror what is seen in individuals with chronic hookworm infection residing in endemic areas. To this end, we compared our findings in the CHHIL participants with those seen in Indonesians living in Flores, an area endemic for soil-transmitted helminths, that had hookworm infection with or without other soil-transmitted helminths (HW+; Table S4)10. To allow comparisons across datasets, we manually gated pDC and basophils from the CHHIL participants and HW+ Flores residents (Fig. S3). The frequencies of pDC and basophils in HW+ Flores residents were comparable to those seen in the CHHIL participants two years post-infection (Fig. 2F). We also tested the functional responses of pDC by stimulation with R-848 (Resiquimod), a TLR-7/8 ligand, and measurement of intracellular cytokine production (Fig. S4A, Table S3). The analysis revealed that the frequencies of IFNα- and TNF-producing pDC decreased over time in the CHHIL participants and, at two years post-infection, frequencies approached those seen in HW+ Flores residents (Fig. 2G), except for one outlying CHHIL donor (D1). These findings indicate that chronic, two-year exposure to a primary hookworm infection leads to similar changes in pDC frequency and functionality as seen in hookworm-infected subjects in endemic areas.
Hookworm infection induces the rearrangement of the Tregs compartment
Modulation of host Tregs, which can promote the survival of helminths within their host11,12, is one of the hallmarks of helminth infections10. Therefore, the fact that changes in immune profiles after controlled human hookworm infection were driven, among others, by Tregs, provided the opportunity to examine these cells together with data from individuals living in helminths-endemic areas, to see how closely changes in Tregs after primary hookworm infection resembled those seen in endemic areas. To this end, Tregs from CHHIL participants and HW+ Flores residents before and after one year of deworming (Fig. 3 A) were manually gated from mass cytometry datasets (Fig. S3), integrated with cyCombine, and used as input for FI-tSNE dimensionality reduction as well as clustering using Cytosplore, which enables interactive exploration of mass cytometry datasets and identification of rare cell clusters (Fig. 3B).
We then examined changes in Tregs composition after primary hookworm infection. Total Tregs frequencies did not change significantly two years after infection, despite a significant decrease at 52 WPI (Fig. S5 A, P = 0.024). However, further analysis of Tregs cluster composition using multilevel PCA revealed segregation of the Tregs profile before and after infection (Fig. 3C, PERMANOVA P < 0.001). The segregation of the Tregs profile was driven by the increase of resting Tregs clusters (Tregs1 and 2) and effector Tregs cluster 4 (CTLA4+ICOS+CD38hi) frequencies, as well as the decrease of the remaining effector Tregs clusters (Tregs5, 9, 10) (Fig. 3D and Fig. S5B). The changes in the resting and effector Tregs clusters could occur as early as 4 WPI and persist up to 104 WPI (Fig. 3D and Fig. S5C; Supplementary Data 3).
Within the time points measured after hookworm infection, we found that the Tregs profile at 4 WPI segregated from the other time points (Fig. S5D). At this time point, the frequencies of ICOS-expressing effector Tregs cluster 4 were increased (Fig. 3D). Knowing that pDC can induce ICOS expression on Tregs13, we found a strong positive correlation between pDC frequencies and Tregs expressing ICOS (Fig. 3E, Pearson r = 0.84, P = 0.009). Given the distinctiveness of the Tregs profile at 4 WPI, we also considered the possibility that the clustering-based analysis might obscure fine-grained changes occurring within this time frame. To this end, we used Milo to perform differential abundance analysis on partially overlapping neighborhoods of cells14, enabling such analysis without having to discretize cells into computationally driven clusters. Performing Milo analysis on the Tregs data was feasible, unlike for pDC and basophils, as the number of markers in our mass cytometry panel unraveled sufficient heterogeneity for Tregs. This analysis showed an enrichment of neighborhoods of TH2-like Tregs cluster 7 (Fig. 3F).
As noted in the changes post-infection (Fig. S2 and Supplementary Data 2), the frequencies of TH2 cells decreased between 0 and 4 WPI (Table S2, cluster 16, FDR = 0.093), in parallel with the enrichment of TH2-like Tregs. As activated non-regulatory CD4+T cells can transiently express Foxp315,16, we asked whether TH2 and TH2-like Tregs form a continuum of closely related subpopulations, or instead represent two well-separated clusters. To this end, the mass cytometry data of TH2 and TH2-like Tregs were fed into PHATE dimensionality reduction, which preserves patterns in the data, such as trajectories and clusters17. We found that the TH2 and TH2-like Tregs formed a continuum of cells and that the trajectory structure of the latter was associated with CD38 expression, a marker of T cell activation (Fig. 3G). These results suggest that the TH2-like Tregs are phenotypically related to TH2 cells and raise the possibility that the former might arise from the latter upon activation.
Taken together, in-depth analysis captured dynamic processes taking place within four weeks of infection. pDC may interact with Tregs leading to upregulation of ICOS expression, proposed to be associated with enhanced Tregs function, while enriched neighborhoods of TH2-like Tregs could be found that seem to arise from related activated TH2 cells.
To answer the question of whether Tregs phenotype changes seen upon controlled hookworm infection resemble what is seen in hookworm-infected subjects from endemic areas, we compared changes in Tregs found in CHHIL donors with those seen in HW+ Flores residents before and after one year of deworming. The increase in frequencies of resting Tregs in CHHIL donors (Fig. 3H, CHHIL) mirrored their decrease upon deworming in Flores residents (Fig. 3H, Flores). Thus, higher resting Tregs frequencies were associated with hookworm infection in both controlled and endemic settings. There were, however, also differences in Tregs phenotype and function between the two cohorts. The frequency of effector Tregs cluster 4 (CCR7+CTLA4+ICOS+CD38hi) was higher in HW+ Flores residents compared to the average of post-infection CHHIL time points (4 to 104 WPI) (Fig. 3I, P = 0.029) and decreased after deworming (P = 0.021). To determine differences in Tregs functional capacity, we analyzed the surface expression of tumor necrosis factor receptor 2 (TNFR2) and TGF-β1 latency-associated peptide (LAP) on Tregs and also the percentage of suppression of responder T cell (Tresp) proliferation with Tregs suppression assay. The frequencies of Tregs expressing TNFR2 and LAP were higher in HW+ Flores residents than in CHHIL participants at 104 WPI (Fig. 3J and Fig. S4B). The percentage suppression by Tregs was higher in HW+ Flores residents compared to CHHIL donors, particularly at a 1:1 Tresp:Tregs ratio (Fig. 3K, P = 0.028; Fig. S5E).
Taken together, we found that primary hookworm infection lasting two years caused a significant remodeling of the Tregs compartment, as evidenced by increased frequencies of resting Tregs, which was paralleled in the profile seen in endemic areas, yet markers of Tregs function were distinct, suggesting that Tregs from endemic settings have stronger suppressive activity.
Development of hookworm-specific CD4+ T cells responses
Within the CD4+ T cell compartment of CHHIL participants, ten clusters changed significantly in frequencies throughout the infection (Fig. 4A). These clusters included naïve and memory CD4+T clusters, as well as TH1 and TH2 cell subsets. Regarding the naïve and memory CD4+ T cells, we observed that a naïve cluster (cluster 3) increased in frequency whereas memory CD4+T clusters (clusters 9, 13, 14, 17, 19) decreased within 4 WPI (Fig. 4A), which might reflect a response to an inflammatory process. We then mapped the development of antigen-specific responses by analyzing the frequencies of CD4+T cells producing TH1 or TH2 cytokines upon stimulation with hookworm crude antigen extract (Fig. S4C). At baseline and 4 WPI, the CD4+ T cells cytokine responses to crude larval antigen of the rodent hookworm Nippostrongylus brasiliensis were negligible (Fig. 4B). At 8 WPI, cytokine-producing cells were detected and the responses peaked at week 12 (Fig. 4B). After 104 WPI, the frequency of IL-4/IL-5/IL-13-producing CD4+T cells remained detectable for three out of three donors, while IFNγ and TNF responses contracted after 28 WPI in all CHHIL participants.
To investigate changes in immune signature preceding the development of the antigen-specific response, we examined the phenotype of CD4+ T cells expressing CD38, which can indicate recently activated memory T cells18. To this end, we manually gated CD38hi cells from the CD4+T clusters analyzed in Fig. 4A. At 4 WPI, we observed a significant increase in CD38hiCD4+T cell frequencies that remained elevated until 12 WPI and then normalized (Fig. 4C). Further exploration of these CD38hiCD4+T cells revealed an increase in CD45RO+ cells that partially co-expressed ICOS, PD-1, or CTLA-4 (Fig. 4D), which could indicate the initial activation and expansion of antigen-specific cells, followed by a subsequent contraction in long-term infection.
Relating the emergence of antigen-specific cytokine responses to the occurrence of hookworm-related symptoms, it was observed that the peak of TH1 and TH2 cytokines corresponded to the time points when the majority of gastrointestinal symptoms were reported at 8 and 12 WPI, respectively (Table 1), suggesting that the occurrence of adverse events might be related to the increase of antigen-specific CD4+T cell cytokine responses.
Table 1.
0 WPI | 4 WPI | 8 WPI | 12 WPI | 28 WPI | 52 WPI | 104 WPI | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | |
Adverse eventsa | ||||||||||||||||||||||||||||
Rash | X | X | X | |||||||||||||||||||||||||
Itching | X | X | X | |||||||||||||||||||||||||
Sore throat | X | |||||||||||||||||||||||||||
Cough | X | |||||||||||||||||||||||||||
Nausea | X | |||||||||||||||||||||||||||
Vomiting | X | |||||||||||||||||||||||||||
Bloating | X | X | ||||||||||||||||||||||||||
Abdominal pain | X | X | X | X | ||||||||||||||||||||||||
Diarrhea | X | X | ||||||||||||||||||||||||||
Cytokines# | ||||||||||||||||||||||||||||
IL-4/IL-5/IL-13 | + | + | + | + | + | + | + | + | + | + | ||||||||||||||||||
IFNγ | + | + | + | + | + | + | + | + | ||||||||||||||||||||
TNF | + | + | + | + | + | + | + | + | + | + | + | + | + |
WPI week post-infection.
aOccurrence of adverse events at a particular time point (±1 week) for a particular donor is indicated with a cross mark (X). #Detection of antigen-specific CD4 + T cytokines is indicated with a plus symbol (+).
Altogether, the controlled infection enabled us to map the dynamic changes of CD4+T cells in detail. We found that after hookworm infection, substantial T cell trafficking within the first 4 WPI and that an increase in CD4+T cells that are expressing CD38, a molecule strongly associated with in vivo T cell activation, precedes the development of hookworm antigen-specific TH1 and TH2 responses, which peak at 12 WPI.
Discussion
Helminths, including hookworms, are experts at modulating the immune response of their hosts19,20. Through the combination of a controlled human hookworm infection model and high-dimensional immunophenotyping, using mass cytometry, we show that a first-in-life hookworm infection with 50 Na-L3 larvae lasting two years remodels the immune system characterized by alterations in circulating immune cells that comprised of pDC, basophils, Tregs, as well as CD4+T cells (Fig. 5). These profiles were compared with data generated on samples collected from naturally infected individuals from Flores island in Indonesia, an area endemic for hookworm.
Notably, we found evidence of pDC modulation by hookworm, seen as increased pDC frequencies and reduced cytokine production after TLR-7/8 activation in both CHHIL participants and hookworm-infected subjects from Flores. pDC are activated by viral21 or host-derived nucleic acids resulting from tissue injury22, which might occur during the migration of hookworm larvae through their human host. When activated, pDC produce large amounts of type I interferon and express inducible co-stimulatory ligand (ICOS-L), among others. ICOS-L expression on pDC have been shown to induce Tregs via ICOS binding13,23–25. In agreement, we found that the frequencies of pDC and ICOS-expressing Tregs cluster were both increased between 0 and 4 WPI and their frequencies were highly correlated. Given the short half-life of pDC26, the reduced cytokine production after in vitro TLR-7/8 stimulation might indicate perpetual modulation of pDC by the ongoing hookworm infection.
Another hallmark of Tregs rearrangement among the CHHIL participants was the increase of resting Tregs upon infection, which was also observed in hookworm-infected individuals from Flores. Resting Tregs are long-lived and required for the maintenance of Tregs populations27, despite being less functional than effector Tregs16,28. Effector Tregs, on the other hand, may proliferate rapidly and migrate to tissues upon activation29. Therefore, given the relatively stable frequency of total Tregs throughout infection, it appears that upon hookworm infection, resting Tregs increase to maintain the circulating Tregs pool at a relatively constant level while effector Tregs migrate to peripheral organs. This is supported by a previous study by Croese and colleagues, who described increased Tregs frequencies in the duodenum despite unaltered Tregs frequencies in the peripheral blood of celiac disease patients who had received experimental hookworm infection30.
We also found an enrichment of Tregs expressing CRTH2, a TH2 cell marker, which according to our trajectory analysis could originate from activated conventional TH2 cells transiently expressing Foxp315,31,32. However, there is also the possibility that Tregs start to express TH2 cell markers. There is increasing interest in regulatory T cells expressing GATA3 or Tbet and their role in controlling adaptive immune responses under specific type 1 or type 2 inflammatory conditions in tissues33–35. Further studies are needed to establish the origin of these cells and their role in controlling type 2 inflammation during hookworm infections. For example, T-cell receptor (TCR) clonal tracing analysis of both TH2 and Tregs could show whether the TCR clonotype between these subsets overlaps and thereby provide evidence of developmental association36.
Despite numerous changes in the Tregs compartment after controlled infection, which in part resembled naturally occurring infections in an endemic setting, we found differences in markers of Tregs function: the suppressive capacity and frequencies of Tregs expressing LAP and TNFR2 were higher in Flores residents than CHHIL participants. This could be explained by the higher and continuous exposure to helminths or the presence of co-infections common in an endemic area. This disparity in the Tregs functional markers may help explain the modest efficacy, if any, of therapeutic experimental hookworm infections37–40.
In agreement with previous studies7, we found antigen-specific CD4+T cells expressing TH1 (IFNγ and TNF) before TH2 (IL-4, IL-5, IL-13) cytokines. We extended this to show that the frequencies of hookworm-specific TH2 cells, but not TH1 cells, remained elevated for up to two years after infection. Before the detection of hookworm-specific cytokine responses, we observed an increase in the frequencies of CD38hiCD4+T cells. This is consistent with the observation that CD38 expression can accurately identify activated T cells in vivo41. In fact, within the CD38hiCD4+T cells, we observed an enrichment of CD45RO+ cells expressing ICOS, PD1, and CTLA4, which implies strong activation of these CD4+T cells, parallel to the development of antigen-specific responses.
Although our study only involved four volunteers, we were able to detect significant patterns of change even after controlling for false discovery. However, several drawbacks need to be considered. The controlled hookworm infection was only given once, which is not representative of naturally occurring infections in endemic areas. Nonetheless, the comparison between CHHIL donors and Flores residents with chronic helminth infections revealed some similarities regarding the effects of hookworms on pDC and Tregs. Moreover, the focus on the circulating immune cells, which are more accessible than the duodenal epithelium, can result in the capture of signals that do not reflect the host’s response to hookworm infection in tissues. Lastly, we did not include non-infected controls, which may help to disentangle fluctuations in the immune profile due to changes occurring over time. However, Liston and colleagues have shown that the immune phenotype within an individual is highly stable over time and may return to the initial equilibrium following perturbations, such as an acute infection or vaccination42.
Taken together, we demonstrate that a single dose of first-in-life hookworm infection lasting two years resulted in a considerable remodeling of both innate and adaptive immune compartments. Comparison of immune cells from controlled infection donors with those from individuals living in the helminth-endemic area showed some resemblance between controlled and natural infections occurring in endemic areas, but also clear differences that can stem from continuous rather than bolus exposure to hookworm infections or other coinfections. Our study provides an important step in our understanding of the modulation of the human immune system by hookworms.
Methods
Controlled human hookworm infection trial
This trial was approved by the local institutional review board (protocol P17.001) and is registered at clinicalTrials.gov (NCT03126552). Healthy volunteers aged 18 to 45 years were recruited and provided written informed consent for enrolment in this trial9. Information regarding exclusion criteria, production of infective N. americanus L3 larvae, and procedure of infection have been extensively described elsewhere. Briefly, the exclusion criteria included, but were not limited to, body mass index below 18 or above 30, iron deficiency anemia, positive fecal tests for soil-transmitted helminths, albendazole contraindications, or planned travel to a hookworm-endemic area.
Necator americanus L3 larvae were produced according to the principles of good manufacturing practice. The fecal specimen containing N. americanus eggs was cultured for seven days before larvae harvest. The identity and viability of the infectious larvae were confirmed by PCR and microscopy. The larvae were used for infection within ten days after harvesting. Fifty N. americanus L3 larvae were dispensed within 15 min after preparation onto four gauzes, which were applied to the dorsal side of volunteers’ upper arms and calves, respectively, for 60 min. Adverse events were recorded and the total eosinophil count and hemoglobin level were measured weekly during the first twelve weeks and six and twelve months after infection. For every adverse event, the time and date of onset and end, severity, and cause were recorded. The clinical trial physician classified adverse events into one of the following categories: unrelated or unlikely, possibly, or definitely related.
Parasitological assays
Fecal samples were collected weekly from 5 WPI onward and checked for N. americanus eggs by Kato-Katz. Two microscopy slides per fecal sample were prepared and both were read by two different technicians. The total number of counted eggs was then multiplied by 20 and expressed as eggs per gram of feces (EPG).
PBMC cryopreservation
Heparinized venous blood was diluted 1:1 with Hanks’ balanced salt solution (HBSS; Invitrogen, 24020-133), containing penicillin G sodium (100 U/ml) and streptomycin (100 U/ml). PBMC were isolated using 1.077 Ficol density gradient centrifugation. PBMC were washed twice with HBSS and then cryopreserved in RPMI 1640 (Invitrogen, 42401-042) containing 20% heat-inactivated fetal calf serum (FCS; Bodinco, CP15-1439) and 10% dimethylsulfoxide (DMSO; Merck Millipore), 1 mM pyruvate, 2 mM L-glutamine, penicillin G, and streptomycin. Cryovials containing cell suspension were transferred to a Mr. Frosty freezing container (Thermo Fisher), which was placed in a −80 °C freezer for four to 20 h before long-term storage in liquid nitrogen.
Deworming of Flores residents chronically infected with helminths
The Flores individuals were part of the SugarSPIN trial, a household-based cluster-randomized double-blind deworming trial conducted in Nangapanda, Ende district of Flores Island, Indonesia43. The trial is registered as a clinical trial at the ISRCTN registry (reference no. ISRCTN75636394). Written informed consent was obtained from all participants before the study. Fifty-six helminth-infected individuals were recruited and treated with 400 mg of albendazole for three consecutive days. The anthelmintic regimen was administered every three months for a total of four rounds. Blood and stool samples were collected before the start of the anthelmintic regimen and at the end of the four rounds.
Of the ten Flores individuals that were analyzed using mass cytometry in our previous study10, eight individuals were included in this study based on the presence of hookworm infection (Table S4). Three additional Flores residents with hookworm infection were selected for intracellular cytokine staining assays (Table S4). Details on PBMC cryopreservation, as well as on mass cytometry antibody staining, data acquisition, and data analysis have been described elsewhere10. The mass cytometry panel used to analyze the Flores samples was similar to the panel used for the CHHIL study (Table S1) except for CD45RA (113CD-labelled, HI100 clone, eBioscience, Cat# 83-0458-42, 1:100 dilution) and that the Flores samples were not barcoded.
Hookworm crude antigen preparation
Nippostrongylus brasiliensis (rodent hookworm) adult worms maintained in Wistar rats were kindly provided by Dr. Benjamin Dewals. Briefly, rats were infected subcutaneously with 5000 L3 larvae purified from fecal cultures. At day eight post-infection, the rats were euthanized, and the intestine recovered for isolation of adult worms in Hank’s buffer using a modified Baermann’s apparatus44. The worms were then decanted from excess media and stored at −80 °C. Adult worm crude antigen extract was prepared by lyophilization, homogenization, and sonification on ice. The antigen was then centrifuged and filter-sterilized. Antigen concentration was measured using a BCA assay kit (Pierce BCA Protein Assay Kit, Thermo Scientific) following the manufacturer’s instructions. Lastly, to check for lipopolysaccharide (LPS) contamination, human embryonic kidney cells (HEK) were stimulated with worm antigen, and IL-8 was measured in the supernatant by ELISA. The antigen extract was then aliquoted and stored at −70 °C.
Intracellular cytokine staining assay with flow cytometry
Hookworm-specific responses
Cell culture
Cells were thawed, washed in RPMI 1640 supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, 1 mM pyruvate, 2 mM glutamate, and 10% FCS, and adjusted to a concentration of 5 × 106 cells/ml. Co-stimuli αCD28 (BD Bioscience) and αCD49d (BD Bioscience) were added at a concentration of 1 µg/ml. Cells were then stimulated with 5 µg/ml antigen extract, 200 ng/ml staphylococcal enterotoxin B (SEB; Sigma-Aldrich), and 10% FCS/RPMI for 24 h at 37 °C under 5% CO2. At the last four hours of stimulation, 10 µg/ml brefeldin A (Sigma-Aldrich) was added.
Flow cytometry antibody staining
After stimulation, cells were then washed twice in phosphate-buffered saline (PBS), stained for viable cells with LIVE/DEADTM Fixable Aqua (Thermofisher), and fixed with 1.9% paraformaldehyde (Sigma-Aldrich) in PBS. Subsequently, cells were washed in FACS buffer (0.5% BSA in PBS, Roche, and 2 mM EDTA, Sigma-Aldrich) and then permeabilized with eBioscienceTM Permeabilization Buffer (ThermoFisher). Cells were stained in a 96-well V-bottom plate with 50 μL of flow cytometry panel antibody mixture (Table S3) diluted in eBioscience™ permeabilization buffer (ThermoFisher) with 1% human Fc receptor blocker (eBioscience) at 4 °C for 30 min. Cells were then resuspended in the FACS buffer before acquisition.
Cell acquisition
Stained cells were acquired with a FACSCanto II flow cytometer (BD Biosciences). The compensation matrix was set using single-stained compensation beads (BDTM CompBead). FCS files were analyzed with the FlowJo v10 software (BD Life Sciences), where positions of gates were guided with fluorescence-minus-one (FMO) or unstimulated controls.
Polyclonal responses to PMA/Ionomycin and R-848
Cell culture
PBMC were thawed as described above. For assessment of intracellular cytokine expression via spectral cytometry, cells were washed in RPMI 1640 (ThermoFisher), supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, 1 mM pyruvate, 2 mM glutamate, and 10% FCS (Greiner Bio-One), and adjusted to a concentration of 1 × 106 cells/ml. Cells were then resuspended in 100 µl RPMI + 10% FCS and stimulated for 6 h with PMA (100 ng/ml, Sigma-Aldrich) and ionomycin (1 µg/ml, Sigma-Aldrich) at 37 °C under 5% CO2. After 4 h of stimulation, 10 µg/ml Brefeldin A (Sigma-Aldrich) was added.
Flow cytometry antibody staining
After stimulation, cells were washed twice in phosphate-buffered saline (PBS), stained for viable cells with LIVE/DEADTM Fixable Blue (Thermofisher), washed again twice in FACS buffer (PBS supplemented with 0.5% BSA, Roche) and 2 mM EDTA (Sigma-Aldrich), and incubated with Human TruStain FcX™ (BioLegend) and True-Stain Monocyte Blocker™ (BioLegend) according to the manufacturer’s instruction for 5 min at room temperature (RT). The antibody surface cocktail, prepared in Brilliant Stain Buffer Plus (BD Biosciences) was added to the cells and incubated for 30 min at RT. The list of antibodies can be found in Table S3. Cells were then washed twice in FACS buffer and afterward fixed and permeabilized with the eBioscienceTM Foxp3 Transcription Factor Staining Buffer Set (ThermoFisher) for 30 min at 4 °C. Subsequently, cells were washed twice with the Permeabilization buffer from the eBioscienceTM Foxp3 Transcription Factor Staining Buffer Set before being incubated with Human TruStain FcX™ and True-Stain Monocyte Blocker™ for 5 min at 4 °C and then stained with the intracellular/intranuclear antibody cocktail for 30 min at 4 °C (Table S3). Lastly, cells were washed with eBioscienceTM Permeabilization buffer followed by another wash in FACS buffer. All centrifugation steps before fixation were performed at 300 g at room temperature (RT) and after fixation at 800 g at 4 °C.
Cell acquisition
For acquisition, cells were resuspended in FACS buffer and acquired on a 5L-Cytek Aurora instrument at the Leiden University Medical Center Flow Cytometry Core Facility (https://www.lumc.nl/research/facilities/fcf/) with the SpectroFlo® v2.2.0.3 software (Cytek Biosciences). As reference controls, an unstained cell sample and single-stain reference controls were used. Single-stain reference controls were either one million PBMC or 50 µl UltraComp eBeads™ (Invitrogen). All reference controls underwent the same protocol as the fully stained samples, including washes, buffers used, and fixation and permeabilization steps.
Regulatory T cells (Tregs) suppression assay
CD4+CD25- responder T cells (Tresp) and CD4+CD25hi regulatory T cells (Tregs) were isolated via magnetic activated cell sorting (MACS) using the CD4+CD25+ Regulatory T Cell Isolation Kit (Miltenyi Biotec GmBH, 130-091-301). A two-step isolation was performed according to the manufacturer’s recommendation, in which first CD4+ cells were isolated, followed by a separation step of CD4+CD25hi Tresp and CD4+CD25hi Tregs. After isolation, cells were rested overnight at 37 °C and 5% CO2. CD4+CD25- Tresp (5 × 104) was labeled with CFSE (Sigma-Aldrich, 21888-25MG-F) and co-cultured with an equal number (ratio of 1:1) or a decreasing number of CD4+CD25hi Tregs (ratios of 5:1 or 10:1). Co-cultures, Tresp alone (ratio of 1:0) or Tregs alone (ratio of 0:1) were stimulated with anti–CD2/CD3/CD28-coated beads at a bead to cell ratio of 1:1 (Miltenyi Biotec; 130-092-909). On day 5 of culture, cells were harvested, washed twice in phosphate-buffered saline (PBS), and stained for viability using the LIVEDEAD Blue Kit (Thermo Fisher Scientific, L23105). Subsequently, cells were washed twice in FACS buffer (0.5% BSA in PBS, Roche, and 2 mM EDTA, Sigma-Aldrich) and stained with the surface antibody cocktail for 30 min at RT. The antibody surface cocktails were prepared in FACS buffer containing 10% Brilliant Stain Buffer Plus (BD Biosciences). The list of antibodies can be found in Table S3. Cells were then washed twice in FACS buffer, fixed, and permeabilized with the eBioscienceTM FoxP3 Transcription Factor Staining Buffer Set (ThermoFisher) for 30 min at 4 °C. Subsequently, cells were washed twice with FACS buffer and stored overnight in the refrigerator. The next day, cells were washed with permeabilization buffer from the eBioscienceTM FoxP3 Transcription Factor Staining Buffer Set before being incubated with the intracellular/intranuclear antibody cocktail for 30 min at 4 °C (Table S3). Lastly, cells were washed with eBioscienceTM Permeabilization buffer followed by another wash in FACS buffer. All centrifugation steps before fixation were performed at 450 x g at RT and after fixation at 800 x g at 4 °C. The proliferation of viable responder T cells was determined by CFSE expression via flow cytometry in live singlet CD3+CD4+ T cells (Fig. S5 E). The percentage (%) of suppression of Tresp proliferation by Tregs was calculated as follows for each Tresp:Tregs ratio: (1 – (Tresp proliferation with Tregs / Tresp proliferation without Tregs)) x 100%.
Ex vivo immunophenotyping with mass cytometry
Nine pre-conjugated metal-tagged antibodies were obtained from Fluidigm (Fluidigm, CA, USA) while 24 + 6 purified monoclonal antibodies were obtained from BioLegend, 2 from Miltenyi, and 1 from eBioscience and conjugated in-house using Maxpar® X8 Antibody Labeling Kits (Fluidigm) or MaxPar® MCP9 Antibody Labeling Kits (Fluidigm) according to the manufacturer’s instructions. Based on titration performance, the in-house conjugated antibodies were stored in Candor PBS-based Antibody Stabilization solution (Candor Biosciences, Germany) with azide at 4 °C. The list of antibodies used is presented in Table S1.
Sample preparation and mass cytometry antibody staining
All centrifugations before fixation were performed at 400 g for 5 min at RT and after fixation at 800 g for 5 min at RT. PBMC were thawed as described above and 3.5 × 106 cells per sample were washed twice in 2 ml Maxpar® Cell Staining Buffer (CSB; Fluidigm). Next, cells were stained with 100 µl barcode antibodies in CBS for 30 min at RT. β−2 microglobulin barcodes (106 Cd, 110 Cd, 111 Cd, 112 Cd, and 114 Cd, 116 Cd; Table S1) were used in a 6-choose-2 combination to multiplex the samples. Samples were separated into two batches with 15 samples in each batch, including a replicate reference sample. Samples were then pooled accordingly, washed twice in CSB, and then 1 ml of rhodium-containing intercalator solution (Cell-ID™ Intercalator-Rh, Fluidigm, diluted 1:500 in CSB) was added for viability staining. To both batches 10 µl anti-Fcγ receptor (BioLegend) was added and incubated for 10 min, before cells were stained in a 200 µl surface antibody cocktail, containing the surface antibodies (Table S1) in CSB for 45 min at RT. Cells were then washed twice in CSB followed by permeabilization using Foxp3 transcription factor staining buffer (eBioscience). For this, cells were incubated for 45 min at 4 °C, protected from light, in a 2 ml working solution. After that, cells were washed twice in Foxp3 Permeabilization buffer (eBioscience) and stained in a 200 µl intracellular antibody cocktail, containing each of the intranuclear antibodies (Table S1), for 30 min at RT, protected from light. Subsequently, cells were washed once with 1x Permeabilization buffer and twice with CSB, before DNA staining with 1 ml of 1x iridium-containing intercalator solution (1000x Cell-ID™ Intercalator-Ir (Fluidigm), diluted 1:1000 in Maxpar® Fix and Perm Buffer) at 4 °C overnight. Lastly, cells were washed twice in 2 ml CSB, divided into samples containing 7.5 × 106 cells/ml in 1 ml 10% DMSO 20% FCS/RPMI, and prepared for storage in liquid nitrogen as described above.
Mass cytometry cell acquisition
On the day of acquisition, cells were thawed in 1 ml 20% FCS/RPMI and washed in 2 ml CSB. Data were acquired using a Helios™ mass cytometer (Fluidigm). The instrument was tuned, calibrated, and cleaned before use according to the manufacturer’s instructions. Briefly, argon gas was used to generate plasma and to nebulize the cell suspension. EQ beads were confirmed to have a median Eu153 intensity of over 1000 to ensure adequate mass sensitivity. Cell suspensions were acquired with a flow rate of 30 µl/minute. Immediately before the acquisition, cells were resuspended to a concentration of 0.75 × 106 cells/ml in Maxpar® Cell Acquisition Solution (Fluidigm) and supplemented with EQ™ Four Element Calibration Beads (Fluidigm) at a final dilution of 1:10. Cells were measured at an acquisition rate between 200 and 250 events/s. The resulting FCS files were normalized using the bead-based normalization tool of the Helios software version 6.5.358 (Fluidigm).
Mass cytometry data analysis
To obtain live single cells, we first performed automated gating of cells based on Gaussian-derived parameters (center, offset, residual, and width) using the cytofclean R package45 followed by manual gating of live, single CD45+ cells with DNA stain and event length in FlowJoTM V10 for Mac (BD Life Sciences). Live, singlet, immune cells were then debarcoded using the CATALYST R package46. The intensity of the B2M-Cadmium barcode staining was well distinguished (Fig. S6A) and 91.6% of the cells were confidently debarcoded (Fig. S6B). Data were then arcsinh-transformed with a cofactor of 5. The analysis of the reference samples from both batches showed comparable marker intensities (Fig. S6C) and cluster abundances (Fig. S6D), all of which suggested negligible batch effects.
Unsupervised clustering of the whole dataset was performed using FlowSOM with a 20 × 20 SOM grid and 50 iterations (rlen) followed by consensus meta-clustering with ward.D2 linkage47. The resulting meta-clusters were further merged using hierarchical clustering and the optimal number of final clusters was assessed using gap statistic48. The clusters were annotated using expert knowledge of immune cell lineage and subset marker expressions.
For unsupervised clustering of a smaller subset of the data, we used Cytosplore+HSNE with default parameters49. The number of HSNE scales was determined by taking the log of the number of cells and rounding it up. Gaussian mean-shift clustering of the HSNE embedding was performed and then the resulting clusters were exported for further analysis in R.
Dimensionality reduction was performed using either FI-tSNE (FFT-accelerated Interpolation-based tSNE) or PHATE (Potential of Heat-diffusion for Affinity-based Trajectory Embedding). FI-tSNE scales tSNE for very large data sets50 and uses optimized parameters and initialization that allow for a more accurate representation of the global structure of the data51. PHATE is a trajectory-preserving dimensionality reduction algorithm that is better suited for the analysis of cells in a continuum of expression states17.
Neighborhood-level differential abundance level analysis of mass cytometry data was performed using the Milo algorithm14. Milo allows the identification of differentially abundant cells without having to discretize cells into clusters. To build the KNN graph, 15 principal components were used as input and the number of nearest neighbors (k) was tuned to achieve the recommended average neighborhood size (5 * number of samples). The sampling of the KNN graph was done by taking 10% of the graph vertices with a graph refinement scheme. Multiple testing correction of differentially abundant neighborhoods was done using graph-overlap weighting and the SpatialFDR cutoff was set at the 0.1 level.
Manual gating of mass cytometry data was performed using the OMIQ software (www.omiq.ai).
Mass cytometry data integration
Data integration was performed using the cyCombine R package52. Briefly, before the integration, the expression of every marker was converted to ranks, individually for each data set. A SOM with a grid size of 6×6 was applied to the combined datasets. The SOM node labels were then assigned to the original expression values and ComBat batch correction was applied per cluster. The corrected values were capped to the input range for each marker.
Statistical analysis
Statistical analysis was performed using the R statistical software version 4.0.2. Data wrangling and visualization were performed using the tidyverse R package53. Heatmaps were generated using the ComplexHeatmap R package54. A complete list of software and algorithms can be found in Table S5.
Multivariate analysis of changes in immune cell frequencies was performed using principal component analysis (PCA) and permutational multivariate analysis of variance (PERMANOVA). Multi-level PCA was performed using the mixOmics R package to account for repeated measures. PERMANOVA was performed using the adonis function of the vegan R package with 9999 permutations and Euclidean distance.
Comparisons of immune cell frequencies across time points were performed using binomial and gaussian linear mixed models for mass cytometry and intracellular cytokine staining data, respectively55. Post-hoc consecutive (comparing one timepoint against the previous one) and Dunnett’s (comparing post-infection vs. baseline) contrasts were performed using the emmeans R package to obtain P-values and effect sizes.
Unless mentioned otherwise, P-values were adjusted for multiple testing using the Benjamini-Hochberg false discovery correction rate (FDR) method. To ensure a consistent p-value cutoff across comparisons, we applied the FDR correction on all comparisons simultaneously instead of within each comparison; this is similar to the ‘global’ P-value adjustment implemented in the limma R package56. Both FDR and alpha cutoffs were set at the 0.05 level.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Supplementary information
Source data
Acknowledgements
We would like to thank the Flow Cytometry Core Facility at Leiden University Medical Center for assistance with our flow and mass cytometry experiments. This study is part of the EDCTP2 programme supported by the European Union. The Controlled Human Hookworm Infection in Leiden (CHHIL) trial was funded by the Dioraphte Foundation and by NWO Spinoza prize of M.Y. M.D.M. is funded by the Indonesian Endowment Fund for Education (LPDP, Reference No. S-1598/LPDP.3/2016). B.G.D. is a Senior Research Associate of the Fonds de la Recherche Scientifique (F.R.S-FNRS).
Author contributions
Conceptualization: M. Roestenberg, M. Yazdanbakhsh. Funding Acquisition: M. Roestenberg, M. Yazdanbakhsh. Clinical trial setup: M.A. Hoogerwerf, J.J. Janse, M.Roestenberg. Clinical trial samples collection: M.D. Manurung, Y. Kruize, J.J. Janse, T. Supali. Materials and reagents: B.G. Dewals, A. Loukas. Mass cytometry experiments: M.D. Manurung, F. Sonnet, M. König. Flow cytometry experiments: F. Sonnet, M. Coppola, L. de Bes. Data analysis and visualization: M.D. Manurung. Writing: M.D. Manurung, F. Sonnet, S.P. Jochems, M. Coppola, and M. Yazdanbakhsh. All authors critically reviewed and approved the final version for publication.
Peer review
Peer review information
Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work. A peer review file is available.
Data availability
Source data for figures are provided with this paper. Processed mass cytometry data is stored in Zenodo under restricted access (https://zenodo.org/records/10889855). Raw mass and flow cytometry data are available from corresponding authors upon request through a data transfer agreement. Restrictions on access are due to patient confidentiality issues; even pseudonymized data can be related back to individuals in some cases. Source data are provided with this paper.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Mikhael D. Manurung, Friederike Sonnet.
These authors jointly supervised this work: Meta Roestenberg, Mariateresa Coppola, Maria Yazdanbakhsh.
Supplementary information
The online version contains supplementary material available at 10.1038/s41467-024-50313-0.
References
- 1.Loukas A, Maizels RM, Hotez PJ. The yin and yang of human soil-transmitted helminth infections. Int J. Parasitol. 2021;51:1243–1253. doi: 10.1016/j.ijpara.2021.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Jia T-W, Melville S, Utzinger J, King CH, Zhou X-N. Soil-Transmitted Helminth Reinfection after Drug Treatment: A Systematic Review and Meta-Analysis. PLOS Neglected Tropical Dis. 2012;6:e1621. doi: 10.1371/journal.pntd.0001621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA. 2008;299:1937–1948. doi: 10.1001/jama.299.16.1937. [DOI] [PubMed] [Google Scholar]
- 4.de Jong SE, et al. Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity. Nat. Immunol. 2021;22:654–665. doi: 10.1038/s41590-021-00911-7. [DOI] [PubMed] [Google Scholar]
- 5.Sandoval, D. M. et al. Adaptive T cells regulate disease tolerance in human malaria. medRxiv, 2021.2008.2019.21262298, 10.1101/2021.08.19.21262298 (2021).
- 6.Chapman PR, Giacomin P, Loukas A, McCarthy JS. Experimental human hookworm infection: a narrative historical review. PLOS Neglected Tropical Dis. 2021;15:e0009908. doi: 10.1371/journal.pntd.0009908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gaze S, et al. Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathog. 2012;8:e1002520. doi: 10.1371/journal.ppat.1002520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Geiger SM, Fujiwara RT, Santiago H, Corrêa-Oliveira R, Bethony JM. Early stage-specific immune responses in primary experimental human hookworm infection. Microbes Infect. 2008;10:1524–1535. doi: 10.1016/j.micinf.2008.09.003. [DOI] [PubMed] [Google Scholar]
- 9.Hoogerwerf MA, et al. New Insights Into the Kinetics and Variability of Egg Excretion in Controlled Human Hookworm Infections. J. Infect. Dis. 2019;220:1044–1048. doi: 10.1093/infdis/jiz218. [DOI] [PubMed] [Google Scholar]
- 10.de Ruiter K, et al. Helminth infections drive heterogeneity in human type 2 and regulatory cells. Sci. Transl. Med. 2020;12:eaaw3703. doi: 10.1126/scitranslmed.aaw3703. [DOI] [PubMed] [Google Scholar]
- 11.Smith KA, et al. Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths. Mucosal. Immunol. 2016;9:428–443. doi: 10.1038/mi.2015.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Taylor MD, et al. Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J. Immunol. 2005;174:4924–4933. doi: 10.4049/jimmunol.174.8.4924. [DOI] [PubMed] [Google Scholar]
- 13.Faget J, et al. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells. Cancer Res. 2012;72:6130–6141. doi: 10.1158/0008-5472.CAN-12-2409. [DOI] [PubMed] [Google Scholar]
- 14.Dann E, Henderson NC, Teichmann SA, Morgan MD, Marioni JC. Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat. Biotechnol. 2022;40:245–253. doi: 10.1038/s41587-021-01033-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur. J. Immunol. 2007;37:129–138. doi: 10.1002/eji.200636435. [DOI] [PubMed] [Google Scholar]
- 16.Miyara M, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 2009;30:899–911. doi: 10.1016/j.immuni.2009.03.019. [DOI] [PubMed] [Google Scholar]
- 17.Moon KR, et al. Visualizing structure and transitions in high-dimensional biological data. Nat. Biotechnol. 2019;37:1482–1492. doi: 10.1038/s41587-019-0336-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yang J, et al. Antigen-Specific T Cell Analysis Reveals That Active Immune Responses to beta Cell Antigens Are Focused on a Unique Set of Epitopes. J. Immunol. 2017;199:91–96. doi: 10.4049/jimmunol.1601570. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Loukas A, et al. Hookworm infection. Nat. Rev. Dis. Prim. 2016;2:16088. doi: 10.1038/nrdp.2016.88. [DOI] [PubMed] [Google Scholar]
- 20.Maizels RM, Smits HH, McSorley HJ. Modulation of Host Immunity by Helminths: The Expanding Repertoire of Parasite Effector Molecules. Immunity. 2018;49:801–818. doi: 10.1016/j.immuni.2018.10.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Ye Y, Gaugler B, Mohty M, Malard F. Plasmacytoid dendritic cell biology and its role in immune-mediated diseases. Clin. Transl. Immunol. 2020;9:e1139. doi: 10.1002/cti2.1139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Gregorio J, et al. Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J. Exp. Med. 2010;207:2921–2930. doi: 10.1084/jem.20101102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ogata M, et al. Plasmacytoid dendritic cells have a cytokine-producing capacity to enhance ICOS ligand-mediated IL-10 production during T-cell priming. Int. Immunol. 2012;25:171–182. doi: 10.1093/intimm/dxs103. [DOI] [PubMed] [Google Scholar]
- 24.Ito T, et al. Plasmacytoid dendritic cells prime IL-10–producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 2007;204:105–115. doi: 10.1084/jem.20061660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Redpath SA, et al. ICOS controls Foxp3+ regulatory T-cell expansion, maintenance and IL-10 production during helminth infection. Eur. J. Immunol. 2013;43:705–715. doi: 10.1002/eji.201242794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Patel AA, Ginhoux F, Yona S. Monocytes, macrophages, dendritic cells and neutrophils: an update on lifespan kinetics in health and disease. Immunology. 2021;163:250–261. doi: 10.1111/imm.13320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Grant FM, et al. BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppression. J. Exp. Med. 2020;217:e20190711. doi: 10.1084/jem.20190711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Cheng G, et al. IL-2 Receptor Signaling Is Essential for the Development of Klrg1+ Terminally Differentiated T Regulatory Cells. J. Immunol. 2012;189:1780–1791. doi: 10.4049/jimmunol.1103768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Booth NJ, et al. Different Proliferative Potential and Migratory Characteristics of Human CD4+ Regulatory T Cells That Express either CD45RA or CD45RO. J. Immunol. 2010;184:4317–4326. doi: 10.4049/jimmunol.0903781. [DOI] [PubMed] [Google Scholar]
- 30.Croese J, et al. Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease. J. Allergy Clin. Immunol. 2015;135:508–516.e505. doi: 10.1016/j.jaci.2014.07.022. [DOI] [PubMed] [Google Scholar]
- 31.Mantel PY, et al. Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 2006;176:3593–3602. doi: 10.4049/jimmunol.176.6.3593. [DOI] [PubMed] [Google Scholar]
- 32.Gavin MA, et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl Acad. Sci. USA. 2006;103:6659–6664. doi: 10.1073/pnas.0509484103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Sakaguchi S, et al. Regulatory T Cells and Human Disease. Annu Rev. Immunol. 2020;38:541–566. doi: 10.1146/annurev-immunol-042718-041717. [DOI] [PubMed] [Google Scholar]
- 34.Wohlfert EA, et al. GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice. J. Clin. Invest. 2011;121:4503–4515. doi: 10.1172/JCI57456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Levine AG, et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature. 2017;546:421–425. doi: 10.1038/nature22360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Valkiers S, et al. Recent advances in T-cell receptor repertoire analysis: Bridging the gap with multimodal single-cell RNA sequencing. ImmunoInformatics. 2022;5:100009. doi: 10.1016/j.immuno.2022.100009. [DOI] [Google Scholar]
- 37.Blount D, et al. Immunologic profiles of persons recruited for a randomized, placebo-controlled clinical trial of hookworm infection. Am. J. Trop. Med. Hyg. 2009;81:911–916. doi: 10.4269/ajtmh.2009.09-0237. [DOI] [PubMed] [Google Scholar]
- 38.Feary J, et al. Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study. Clin. Exp. Allergy. 2009;39:1060–1068. doi: 10.1111/j.1365-2222.2009.03187.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Feary JR, et al. Experimental hookworm infection: a randomized placebo-controlled trial in asthma. Clin. Exp. Allergy. 2010;40:299–306. doi: 10.1111/j.1365-2222.2009.03433.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Tanasescu R, et al. Hookworm Treatment for Relapsing Multiple Sclerosis: A Randomized Double-Blinded Placebo-Controlled Trial. JAMA Neurol. 2020;77:1089–1098. doi: 10.1001/jamaneurol.2020.1118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Braun J, et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020;587:270–274. doi: 10.1038/s41586-020-2598-9. [DOI] [PubMed] [Google Scholar]
- 42.Carr EJ, et al. The cellular composition of the human immune system is shaped by age and cohabitation. Nat. Immunol. 2016;17:461–468. doi: 10.1038/ni.3371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Tahapary DL, et al. Helminth infections and type 2 diabetes: a cluster-randomized placebo controlled SUGARSPIN trial in Nangapanda, Flores, Indonesia. BMC Infect. Dis. 2015;15:133. doi: 10.1186/s12879-015-0873-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Johnston, C. J. et al. Cultivation of Heligmosomoides polygyrus: an immunomodulatory nematode parasite and its secreted products. J. Vis. Exp. e52412, 10.3791/52412 (2015). [DOI] [PMC free article] [PubMed]
- 45.Bagwell CB, et al. Automated Data Cleanup for Mass Cytometry. Cytom. Part A. 2020;97:184–198. doi: 10.1002/cyto.a.23926. [DOI] [PubMed] [Google Scholar]
- 46.Chevrier S, et al. Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry. Cell Syst. 2018;6:612–620.e615. doi: 10.1016/j.cels.2018.02.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Van Gassen S, et al. FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data. Cytom. Part A. 2015;87:636–645. doi: 10.1002/cyto.a.22625. [DOI] [PubMed] [Google Scholar]
- 48.Tibshirani R, Walther G, Hastie T. Estimating the number of clusters in a data set via the gap statistic. J. R. Stat. Soc.: Ser. B (Stat. Methodol.) 2001;63:411–423. doi: 10.1111/1467-9868.00293. [DOI] [Google Scholar]
- 49.van Unen V, et al. Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types. Nat. Commun. 2017;8:1740. doi: 10.1038/s41467-017-01689-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Linderman GC, Rachh M, Hoskins JG, Steinerberger S, Kluger Y. Fast interpolation-based t-SNE for improved visualization of single-cell RNA-seq data. Nat. Methods. 2019;16:243–245. doi: 10.1038/s41592-018-0308-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Kobak, D. & Berens, P. The art of using t-SNE for single-cell transcriptomics. Nat. Commun.10, 10.1038/s41467-019-13056-x (2019). [DOI] [PMC free article] [PubMed]
- 52.Pedersen CB, et al. cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies. Nat. Commun. 2022;13:1698. doi: 10.1038/s41467-022-29383-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Wickham H, et al. Welcome to the Tidyverse. J. Open Source Softw. 2019;4:1686. doi: 10.21105/joss.01686. [DOI] [Google Scholar]
- 54.Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32:2847–2849. doi: 10.1093/bioinformatics/btw313. [DOI] [PubMed] [Google Scholar]
- 55.Nowicka, M. et al. CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets [version 4; peer review: 2 approved]. F1000Res.6, 10.12688/f1000research.11622.4 (2019). [DOI] [PMC free article] [PubMed]
- 56.Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47–e47. doi: 10.1093/nar/gkv007. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Source data for figures are provided with this paper. Processed mass cytometry data is stored in Zenodo under restricted access (https://zenodo.org/records/10889855). Raw mass and flow cytometry data are available from corresponding authors upon request through a data transfer agreement. Restrictions on access are due to patient confidentiality issues; even pseudonymized data can be related back to individuals in some cases. Source data are provided with this paper.